Drugs / TRC041266
last change Jun 2024 re-read 3 minutes ago

TRC041266

Developed for
heart failure
Investigated by
Torrent Pharmaceuticals Limited

Trials 1

20222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT04507347 Jun 2021 → Jun 2024 heart failure Torrent Pharmaceuticals Limited Withdrawn No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as TRC041266 ClinicalTrials.gov intervention name — accepted as the source's own label NCT04507347 ↗